Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.73)
# 3,517
Out of 5,134 analysts
21
Total ratings
50%
Success rate
1.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Downgraded: Hold | $9 | $7.56 | +19.05% | 1 | Nov 13, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $12 → $10 | $9.16 | +9.17% | 4 | Nov 6, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $32 | $24.49 | +30.67% | 5 | Nov 5, 2026 | |
| ATRC AtriCure | Reiterated: Hold | $36 → $62 | $56.84 | +9.08% | 6 | Nov 4, 2026 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $5.27 | n/a | 5 | Nov 7, 2025 |
NeuroPace
Nov 13, 2026
Downgraded: Hold
Price Target: $9
Current: $7.56
Upside: +19.05%
DENTSPLY SIRONA
Nov 6, 2026
Reiterated: Hold
Price Target: $12 → $10
Current: $9.16
Upside: +9.17%
Envista Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $32
Current: $24.49
Upside: +30.67%
AtriCure
Nov 4, 2026
Reiterated: Hold
Price Target: $36 → $62
Current: $56.84
Upside: +9.08%
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $5.27
Upside: n/a